Spectroscopic and molecular modeling studies of caffeine complexes with DNA intercalators

Biophysical Journal

Volumn 70, Issue 1, 1996, Pages 443-452

  Larsen, Randy W ^a   Jasuja, Ravi ^a   Hetzler, Ronald K ^a   Muraoka, Peter T ^a   Andrada, Vincent G ^a   Jameson, David M ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE ORANGE; CAFFEINE; DNA; DOXORUBICIN; ETHIDIUM BROMIDE; INTERCALATING AGENT; MITOXANTRONE;

ARTICLE; COMPLEX FORMATION; CYTOSTASIS; INTERCALATION COMPLEX; MOLECULAR MODEL; NONHUMAN; PROTEIN DNA INTERACTION; SPECTROSCOPY; STOICHIOMETRY;

EID: 0030069625     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(96)79587-5     Document Type: Article

References (36)

1. Anmoto, S., S, Fukuoka, C. Itome, H. Nakano, H. Rai, and H, Hayatsu. 1993. Binding of polycyclic planar mutagens to chlorophyllin resulting in inhibition of the mutagenic activity. Mutation Res. 287:293-305.
2. Bakhkshiev, N. G. 1961. Universal intermolecular interactions and their effects on the position and electronic spectra of molecules in two-component solutions. Optic. Spectrosc. 10:379-384.
3. Bayliss, N. S., and E. G. McRae. 1954. Solvent effects in organic spectra: dipole forces and the Franck-Condon principle. J. Chem. Phys. 58: 1002-1006.
4. Bertrand, C. A., I. Pomper, G. Hillman, J. C. Duffy, and L Mitchell. 1970. No relation between coffee and blood pressure. N. Engl. J. Med. 299:315-316.
5. Borodina, V. M., E. E. Kirianova, O. V. Federova, and A. V. Zelenin. 1979. Cytochemical properties of interphase chromatin condensed as a result of treatment with caffeine. Exp. Cell Res. 122:391-394.
6. Brun, A. M., and A. Harriman. 1994. Energy- and electron-transfer processes involving palladium porphyrins bound to DNA. J. Am. Chem. Soc. 116:10383-10393.
7. Brunet, J. E., V. Vargas, E. Gratton, and D. M. Jameson. 1993. Hydrodynamics of horseradish peroxidase revealed by global analysis of multiple fluorescence probes. Biophys. J. 66:446-453.
8. Curatolo, P. W., and D. Robertson. 1983. The health consequences of caffeine. Ann. Int. Med. 98:641-653.
9. Damewood, J. R., W. P. Anderson, and J. J Urban. 1988. A molecular mechanics study of neutral molecule complexation with crown ethers. J. Comput. Chem. 9:111-124.
10. Dashwood, R., and D. Guo. 1993. Antimutagenic potency of chlorophyllin in the Salmonella assay and its correlation with binding constants of mutagen-inhibitor complexes. Env. Mol. Mut. 22:164-171.
11. Dews, P., H. C. Grice, A. Neims, I. Wilson, and R. Wurtman. 1984. Report of the fourth international caffeine workshop, Athens. Fd. Chem. Toxicol. 22:163-169.
12. Gratton, E., D. M. Jameson, and R. D. Hall. 1984. Multifrequency phase and modulation fluorometry. Annu. Rev. Bioenerg. 13:105-124.
13. Hartman, P. E., and D. M. Shankel. 1990. Antimutagens and anticarcinogens: a survey of putative interceptor molecules. Env. Mol. Mut. 15:145-182.
14. Jameson, D. M., and E. Gratton. 1983. New Directions in Molecular Luminescence. D. Eastwood and L. Cline-Love, editors. Philadelphia. American Society for Testing Materials. 67-81.
15. Jameson, D. M., E. Gratton, and J. D. Hall. 1984. The measurement and analysis of heterogeneous emissions by multifrequency phase and modulation fluorimetry. Appl. Spectrosc. Rev. 20:55-105.
16. Jameson, D. M., and T. L. Hazlett. 1991. Time-resolved fluorescence in biology and biochemistry. In Biophysical and Biochemical Aspects of Fluorescence Spectroscopy. T. G. Dewey, editor. Plenum Press, New York. 105-133.
17. Jick, H., O. S. Miettinen, R. K. Neff, S. Shapiro, O. P. Heinonen, and D. Slone. 1973. Coffee and myocardial infarction. N. Engl. J. Med. 289:63
18. Kapuscinski, J., and M. Kimmel. 1993. Thermodynamic model of mixed aggregation of interealators with caffeine in aqueous solution. Biophys. Chem. 46:153-163
19. Kimura, H., and T. Aoyama. 1989. Decrease in sensitivity to ethidium bromide by caffeine, dimethylsulfoxide or 3-aimnobenzamide due to reduced permeability. J. Pharmacobiodyn. 12:589-595.
20. Kunicka, J. E., M. R. Melamed, and Z. Darzynkiewicz. 1990. Caffeine increases sensitivity of DNA to denaturation and chromatin of L1210 cells. Cell Tissue Kinetics. 23:31-39.
21. Lakowicz, J. R., H. Cherek, E. Gratton and B. P. Maliwal. 1985. Time-resolved fluorescence amsotropy of diphenyl hexatriene and perylene in solvent and lipid bilayers obtained from multifrequency phase-modulation fluorometry. Biochemistry. 24:376-383.
22. Langley, D. R., T. W. Doyle, and D. L. Beveridge. 1991. The dynemicin-DNA intercalation complex: a model based on DNA affinity cleavage and molecular dynamics simulation. J. Am. Chem. Soc. 113:4395-4403.
23. Levin, R. B. 1982. Influence of caffeine on mutations induced by nitrosoguanidine in Salmonella typhimurium tester strains. Env. Mutagen. 4:689-694.
24. Mann, J. I., and M. Thorogood. 1975. Coffee drinking and myocardial infraction. Lancet. ii:1215.
25. O'Neal, F. J. 1979. Differential effects of cytochalasin B and caffeine on control of DNA synthesis in normal and transformed cells J. Cell Physiol. 101:201-218.
26. Pozniak, P. C. 1985. The carcinogenicity of caffeine and coffee: a review. J. Am. Diet. Assoc. 85:1127.
27. Rall, T. W 1980. Central nervous system stimulants: the xanthines. In The Pharmacological Basis of Therapeutics, 6th ed. L. S. Goodman and A. Gilman, editors. Toronto, Macmillan. 592.
28. Roberts, J. J. 1984. Mechanism of potentiation by caffeine of genotoxic damage induced by physical and chemical agents. In DNA Repair and Its Inhibitors. A. Collins, C. S. Downes, and R. T Johnson, editors. Oxford, IRL Press. 193-216.
29. Ross, W. E., L. A. Zwelling, and K. W. Kohn. 1979. Relationship between cytoxicity and DNA strand breakage by adriamycin and other intercalating agents. Int. J. Radiat. Biol. Phys. 5:1221-1224.
30. Selby, C. P., and A. Sancar. 1990. Molecular mechanism of DNA repair inhibition by caffeine. Proc. Natl. Acad. Sci. USA. 87:3522-3525
31. Spencer, R. D., and G. Weber. 1969. Measurements of subnanosecond fluorescence lifetimes with a cross-correlation phase fluorometer. Ann. NY Acad. Sci. 158:361-376.
32. Spencer, R. D., and G. Weber. 1970. Influence of Brownian rotations and energy transfer upon the measurement of fluorescence lifetimes. J. Chem. Phys. 52:1654-1663.
33. Tachino, N., D. Guo, W. M. Dashwood, S. Yamane, R. W. Larsen. and R. Dashwood. 1994. Mechanisms of the in vitro antimutagenic action of chlorophyllin against benzo(A)pyrene: studies of enzyme inhibition, molecular complex formation, and degradation of the ultimate carcinogen. Mutation Res. 308.191-203.
34. Traganos, F., J. Kapuscinski, and Z. Darzynkiewicz. 1991. Caffeine modulates the effects of DNA-intercalating drugs in vivo: a flow cytometric and spectrophotometric analysis of caffeine interaction with novantrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198. Cancer Res. 51:3682-3689.
35. Weber, G. 1977. Theory of differential phase fluorimetry: detection of anisotropic molecular rotations. J. Chem. Phys. 66.4081-4091
36. Weber, G., 1981. Resolution of the fluorescence lifetimes in a heterogeneous system by phase and modulation measurements. J Phys. Chem. 85:949-953.